#Bivi hashtag - Bluesky

2 weeks ago

BioVie Announces Abstract Accepted for Presentation at AD/PD 2026 BioVie (NASDAQ: BIVI) announced an abstract acceptance for a poster presentation from its SUNRISE-PD study of bezisterim (NE3107) in early Parkinson’s disease at AD/PD 2026, March 17-21 in Copenhagen.The poster, “Demographics and Baseline Characteristics of Participants in a Study of Bezisterim (SUNRISE-PD),” summarizes initial enrolled-patient data. Topline results are expected in mid-2026.

#BIVI BioVie Announces Abstract Accepted for Presentation at AD/PD 2026

www.stocktitan.net/news/BIVI/bio-vie-announ...

0 0 0 0

BioVie Inc

@biovie.bsky.social

1 month ago

BioVie could offer first new Parkinson’s therapy in decades In biotech, the most compelling investment stories often emerge where medical need, scientific differentiation, and timing intersect. BioVie Inc...

#Parkinson’s care has focused on dopamine for decades.
BioVie ($BIVI) is testing a different angle: targeting brain inflammation + insulin resistance.

Phase 2 SUNRISE-PD enrollment complete with topline data expected Apr/May 2026.

Multiple 2026 catalysts ahead.
#Biotech #BIVI

0 0 0 0

BioVie Inc

@biovie.bsky.social

1 month ago

American College of Psychiatrists Annual Meeting Poster Presentations February 18, 2026 Abstract Title: Bezisterim-Associated Anti-inflammatory Epigenetic Modulation of Age Acceleration and Cognition in Alzheimer's Disease Authors: Joseph M. Palumbo; Christopher L. Reading; Jiayan Yan, Clarence Ahlem; Penelope Markham; Stephen O'Quinn; Varun B. Dwaraka Abstract Title: Baseline Characteristics of Currently Enrolled Participants in Phase 2 Study of Bezisterim (NE3107) in Long COVID (ADDRESS-LC) Authors: Joseph M. Palumbo; Penelope Markham; Michael Peluso; Igor J. Koralnik; Sherry Hsiang-Yi Chou; Lisa McCorkell; Chantal Petit; Stephen O'Quinn; Chris Reading; Clarence Ahlem; Jiayan Yan

BioVie announced the acceptance of two abstracts from studies on our lead candidate bezisterim, in the treatment of #Alzheimer’s & #LongCOVID at the upcoming 2026 American College of Psychiatrists (ACP) annual meeting.

Read: investors.bioviepharma.com/news/news-de...

#ScientificExchange #BIVI

2 1 0 0

BioVie Inc

@biovie.bsky.social

2 months ago

THANK YOU #MichaelJFoxFoundation, #DavisPhinneyFoundation, & @parkinsondotorg.bsky.social!

Our team, and the Parkinson’s community at large, is grateful for your fierce dedication to advancing research toward treatments for patients.

#ParkinsonsDisease #Advocacy #PatientCentricResearch #BIVI

0 0 0 0

BioVie Inc

@biovie.bsky.social

2 months ago

Parkinson's Update BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson's Disease

Enrollment is complete in our Phase 2 SUNRISE-PD clinical trial evaluating bezisterim for the treatment of motor & non-motor symptoms in patients with early-stage #Parkinson’s disease. Topline results expected in 1H 2026.

Learn more: investors.bioviepharma.com/news/news-de...

#Neurology #BIVI

2 0 0 0

佐藤正実

@kazenotoki.bsky.social

3 months ago

Biviの2階〜4階は改装工事中。どんなお店が入るんだろう。

明日発売する『バック・トゥ・ザ・センダイ』第一便、発送完了♩
お買い上げありがとうございます♩
#仙台 #東口 #Bivi

3 0 0 0

StockTitan

@stocktitan.net

4 months ago

#BIVI Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9

www.stocktitan.net/news/BIVI/join-biovie-s-...

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

4 months ago

Leading Indicators, Tuesday November 11, 2025 – Crystal Equity Research

Small-cap stocks with declining money flow, Tue Nov 11th - #THM #ULBI #TASK #SDST #RR #QTTB #OM #NB #KRMD #JACK #III #HUMA #GIC #FOXF #ENGN #CCSI #BIVI #ABAT #KLC #HY #EBF #DHO #CNNE #BNED #AMN - More: crystalequityresearch.com/leading-indi... - #smallcap

0 0 0 0

濃藍-Koiai

@blueblack-kouji.bsky.social

4 months ago

列に並んでる中、撮影するのに隙間作ってくださった方々、ご迷惑おかけしました。ありがとうございます。

YouTubeで見た「らぶぶ(ラブブ？張り紙のはLABUBUって書いてありました)」のポップアップストアが厚別区にも来てました！人気なんですね。

＃らぶぶ
＃ラブブ
＃LABUBU
＃札幌市
＃厚別区
＃BiVi
＃新さっぽろ

0 0 0 0